Cargando…
Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders
BACKGROUND: Lamotrigine is an anticonvulsant drug indicated for the maintenance treatment of bipolar I disorder and for various types of epilepsy. An orally disintegrating tablet (ODT) of lamotrigine was developed to provide a formulation option that might increase patient convenience and satisfacti...
Autores principales: | Sajatovic, Martha, Thompson, Thomas R, Nanry, Kevin, Edwards, Suzanne, Manjunath, Ranjani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653756/ https://www.ncbi.nlm.nih.gov/pubmed/23687443 http://dx.doi.org/10.2147/PPA.S40271 |
Ejemplares similares
-
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015) -
Design of a controlled release liquid formulation of lamotrigine
por: Mishra, B., et al.
Publicado: (2011) -
Increased Anxiety, Akathisia, and Suicidal Thoughts in Patients with Mood Disorder on Aripiprazole and Lamotrigine
por: Pondé, Milena Pereira, et al.
Publicado: (2015) -
Delayed Stevens–Johnson Syndrome Secondary to the Use of Lamotrigine in Bipolar Mood Disorder
por: Jha, Kunal Kishor, et al.
Publicado: (2017) -
Bimodal Gastroretentive Drug Delivery Systems of Lamotrigine: Formulation and Evaluation
por: Poonuru, R. R., et al.
Publicado: (2014)